Waters (NYSE:WAT) Price Target Raised to $180.00 at Citigroup

Waters (NYSE:WAT) had its target price increased by Citigroup from $150.00 to $180.00 in a research note released on Wednesday morning, The Fly reports. They currently have a sell rating on the medical instruments supplier’s stock.

Other equities research analysts have also issued research reports about the company. SVB Leerink dropped their price target on Waters from $210.00 to $195.00 and set a market perform rating for the company in a research note on Wednesday, April 29th. Wells Fargo & Co upgraded Waters from an underweight rating to an equal weight rating and lifted their price objective for the stock from $175.00 to $225.00 in a report on Thursday, July 16th. Zacks Investment Research upgraded Waters from a sell rating to a hold rating and set a $210.00 price objective on the stock in a report on Monday, June 1st. Needham & Company LLC began coverage on Waters in a report on Tuesday, July 28th. They issued a sell rating on the stock. Finally, ValuEngine downgraded Waters from a buy rating to a hold rating in a report on Thursday, April 2nd. Four analysts have rated the stock with a sell rating and eight have assigned a hold rating to the stock. Waters currently has a consensus rating of Hold and an average target price of $196.22.

Shares of WAT stock opened at $213.15 on Wednesday. The business has a 50-day moving average price of $197.00 and a two-hundred day moving average price of $199.83. Waters has a 12-month low of $154.39 and a 12-month high of $245.68. The firm has a market cap of $13.17 billion, a P/E ratio of 26.54, a price-to-earnings-growth ratio of 6.89 and a beta of 0.94.

Waters (NYSE:WAT) last issued its quarterly earnings results on Tuesday, July 28th. The medical instruments supplier reported $2.10 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.47 by $0.63. Waters had a negative return on equity of 349.31% and a net margin of 22.61%. The firm had revenue of $519.98 million during the quarter, compared to analyst estimates of $519.41 million. On average, equities analysts expect that Waters will post 8.2 earnings per share for the current fiscal year.

A number of large investors have recently made changes to their positions in the stock. Ledyard National Bank increased its holdings in Waters by 3.6% during the 2nd quarter. Ledyard National Bank now owns 1,437 shares of the medical instruments supplier’s stock valued at $259,000 after purchasing an additional 50 shares during the period. Brinker Capital Inc. increased its holdings in Waters by 4.1% during the 1st quarter. Brinker Capital Inc. now owns 1,671 shares of the medical instruments supplier’s stock valued at $304,000 after purchasing an additional 66 shares during the period. Oppenheimer Asset Management Inc. increased its holdings in Waters by 9.8% during the 1st quarter. Oppenheimer Asset Management Inc. now owns 785 shares of the medical instruments supplier’s stock valued at $143,000 after purchasing an additional 70 shares during the period. Wesleyan Assurance Society increased its holdings in Waters by 0.8% during the 1st quarter. Wesleyan Assurance Society now owns 10,180 shares of the medical instruments supplier’s stock valued at $1,853,000 after purchasing an additional 80 shares during the period. Finally, Armstrong Henry H Associates Inc. increased its holdings in Waters by 1.0% during the 1st quarter. Armstrong Henry H Associates Inc. now owns 8,169 shares of the medical instruments supplier’s stock valued at $1,487,000 after purchasing an additional 80 shares during the period. Institutional investors own 95.09% of the company’s stock.

Waters Company Profile

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Read More: Learning About the VIX – Volatility Index

The Fly

Analyst Recommendations for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.